Insights from the pioneer of mRNA technology on his background, career, and experiences in the field
-
Reflecting on his career, experiences, and thoughts on the Nobel Prize in the field of mRNA technology. • 0:08
-
Worked on biod defense products and vaccines, interacting with individuals from the ‘deep State’ and CIA connections. • 1:45
-
Significant impact on the scientific community with his insights and perspectives on mRNA technology. • 1:54
-
Robert Malone’s diverse educational background and extensive experience in gene therapy and vaccine development. • 3:16
-
Living a simple life on a horse farm in Northern Virginia with his wife, Dr. Joelglasp Malone. • 3:26
-
Background in pathology, virology, immunology, and molecular biology, with a focus on HIV and gene transfer research. • 4:00
-
Contributions to the field of gene delivery using pulse electrical fields and founding a company based on this technology. • 5:25
-
His involvement in various research projects and collaborations with organizations like the US Army and Gates Foundation. • 6:39
In-depth background on mRNA technology development and patent issues
-
Speaker’s involvement in bringing forward vaccine candidates • 7:40
-
Experience in advancing bio defense products and outbreak response • 8:23
-
Transition from Sulk Institute to Vical for mRNA research • 10:37
-
Patent issues and conflicts with mentor at Sulk Institute • 11:05
-
Discovery of naked DNA and RNA delivery at Vical • 11:15
-
Details on patent filings and abandonment by Sulk Institute • 11:55
-
Innovations in lipid formulations for mRNA delivery • 13:02
-
Challenges faced in the early stages of mRNA technology development • 13:24
Challenges and ethical decisions in mRNA technology development leading to career transitions
-
Challenges faced in developing gene therapy for Cystic Fibrosis • 15:02
-
Struggles with funding and rejection due to perceived delivery problem solved by another entity • 16:35
-
Experience as a whistleblower regarding unethical practices in academia • 18:05
-
Importance of maintaining good relationships and support from colleagues during career setbacks • 19:08
-
Personal growth and sense of security from standing by moral principles despite consequences • 20:08
Personal journey of overcoming trauma, gaslighting, and backlash while standing up for recognition of contributions
-
Overcoming trauma and PTSD diagnosis to speak out with support from spouse • 20:25
-
Encouragement from spouse to share experiences despite past strategy of staying quiet • 20:45
-
Triggered to stand up against erasure of contributions, leading to backlash from media and academia • 22:33
-
Facing backlash and misrepresentation from various media outlets and academic institutions • 25:01
-
Focus on patents over publications leading to weaponization of achievements • 26:12
-
Reflecting on the impact of staying silent versus speaking out against injustice • 26:37
Insights on the recent Nobel Prize decision regarding mRNA vaccine technology
-
Discussion on the therapeutic value of sharing traumatic experiences • 27:03
-
Impact of not being credited for work on mRNA technology • 28:46
-
Consequences faced by individuals for speaking against mainstream narratives • 29:06
-
Surprise and disappointment over Nobel Prize decision • 30:23
-
Committee’s unusual carveout for award related to mRNA vaccines against Co 19 • 32:01
-
Vindication in the fact that award was not for invention of mRNA technology • 33:00
Controversies surrounding the Nobel Prize for mRNA technology originator and its implications
-
Committee’s false assertions about mRNA technology origin and vaccine development • 33:27
-
Nobel Prize justification based on questionable claims and political influence • 33:38
-
Misleading statements in press releases regarding vaccine efficacy and development process • 35:03
-
Use of modified base in mRNA vaccines not the primary reason for rapid development • 36:08
-
Emotional impact of social media attacks following the Nobel Prize announcement • 38:01
-
Recognition received by others involved in mRNA technology research • 40:04
Insights on the impact of mRNA technology on public health and the biomedical industry
-
Science is a challenging field with continuous discoveries and setbacks. • 40:28
-
Emotional resilience required to navigate challenges in public health and technology development. • 41:20
-
Concerns about the misuse of technology and its impact on public trust in health institutions. • 43:05
-
Critique of emergency use authorization and its consequences on global competitiveness in biopharmaceuticals. • 44:04
-
Contradictions in initial virus severity claims and their role in shaping public health responses. • 46:10
-
Acknowledgment of ethical breaches in product development and the need for adherence to international norms. • 47:09
Challenges and risks associated with mRNA technology and lipid nanoparticle delivery systems
-
Regulatory uncertainty in pharmaceutical development space • 47:24
-
Unpredictability in FDA standards and approval processes • 47:36
-
Concerns about compromised integrity of the system • 48:19
-
Risks associated with lipid nanoparticle delivery system • 48:35
-
Data showing high adverse event rate at certain dosage levels • 49:38
-
Importance of lipid formulation technology in mRNA development • 51:00
-
Demonstration of effectiveness without Pseudo iDine in formulations • 52:22
-
Immunosuppressive characteristics and risks of mRNA molecules • 52:44
Insights on mRNA vaccine toxicity and scientific community's response
-
mRNA vaccines share common toxicities like cardiotoxicity and coagulopathy. • 54:00
-
The formulation of mRNA vaccines may contribute to toxicities. • 55:09
-
Complex interaction of lipid particles, mRNA, and spike protein leads to toxicity. • 55:34
-
Questioning why scientific community overlooks potential issues with mRNA vaccines. • 56:11
-
The speaker is puzzled by the ideological perspective surrounding mRNA vaccines. • 56:20
-
A reminder that understanding others’ perspectives is challenging. • 57:10